Correlation Between Sharps Technology and Citius Oncology,
Can any of the company-specific risk be diversified away by investing in both Sharps Technology and Citius Oncology, at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Sharps Technology and Citius Oncology, into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Sharps Technology and Citius Oncology,, you can compare the effects of market volatilities on Sharps Technology and Citius Oncology, and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Sharps Technology with a short position of Citius Oncology,. Check out your portfolio center. Please also check ongoing floating volatility patterns of Sharps Technology and Citius Oncology,.
Diversification Opportunities for Sharps Technology and Citius Oncology,
0.7 | Correlation Coefficient |
Poor diversification
The 3 months correlation between Sharps and Citius is 0.7. Overlapping area represents the amount of risk that can be diversified away by holding Sharps Technology and Citius Oncology, in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Citius Oncology, and Sharps Technology is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Sharps Technology are associated (or correlated) with Citius Oncology,. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Citius Oncology, has no effect on the direction of Sharps Technology i.e., Sharps Technology and Citius Oncology, go up and down completely randomly.
Pair Corralation between Sharps Technology and Citius Oncology,
Given the investment horizon of 90 days Sharps Technology is expected to generate 3.05 times more return on investment than Citius Oncology,. However, Sharps Technology is 3.05 times more volatile than Citius Oncology,. It trades about -0.03 of its potential returns per unit of risk. Citius Oncology, is currently generating about -0.12 per unit of risk. If you would invest 511.00 in Sharps Technology on August 19, 2025 and sell it today you would lose (225.00) from holding Sharps Technology or give up 44.03% of portfolio value over 90 days.
| Time Period | 3 Months [change] |
| Direction | Moves Together |
| Strength | Significant |
| Accuracy | 98.46% |
| Values | Daily Returns |
Sharps Technology vs. Citius Oncology,
Performance |
| Timeline |
| Sharps Technology |
Risk-Adjusted Performance
Weakest
Weak | Strong |
| Citius Oncology, |
Sharps Technology and Citius Oncology, Volatility Contrast
Predicted Return Density |
| Returns |
Pair Trading with Sharps Technology and Citius Oncology,
The main advantage of trading using opposite Sharps Technology and Citius Oncology, positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Sharps Technology position performs unexpectedly, Citius Oncology, can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Citius Oncology, will offset losses from the drop in Citius Oncology,'s long position.| Sharps Technology vs. Lucid Diagnostics | Sharps Technology vs. Microbot Medical | Sharps Technology vs. Sera Prognostics | Sharps Technology vs. Rapid Micro Biosystems |
| Citius Oncology, vs. Scilex Holding | Citius Oncology, vs. Actuate Therapeutics, Common | Citius Oncology, vs. Forte Biosciences | Citius Oncology, vs. Spero Therapeutics |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Commodity Channel module to use Commodity Channel Index to analyze current equity momentum.
Other Complementary Tools
| Price Transformation Use Price Transformation models to analyze the depth of different equity instruments across global markets | |
| Financial Widgets Easily integrated Macroaxis content with over 30 different plug-and-play financial widgets | |
| Positions Ratings Determine portfolio positions ratings based on digital equity recommendations. Macroaxis instant position ratings are based on combination of fundamental analysis and risk-adjusted market performance | |
| Alpha Finder Use alpha and beta coefficients to find investment opportunities after accounting for the risk | |
| Stocks Directory Find actively traded stocks across global markets |